-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G02ncmLQyqqV3TjYH4GVIRH+CNl5BDwi0M3kbpbSdiYIxhDmi4z1x3hj/5qcT2Ny Q2L2a4dc+DabALom9lPFAA== 0000891554-99-001068.txt : 19990623 0000891554-99-001068.hdr.sgml : 19990623 ACCESSION NUMBER: 0000891554-99-001068 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19990524 GROUP MEMBERS: LOGG INVESTMENT RESEARCH INC GROUP MEMBERS: MARK T. SMITH GROUP MEMBERS: THE R. TEMPLETON SMITH FOUNDTATION GROUP MEMBERS: THE ROCKSIDE FOUNDATION GROUP MEMBERS: THOMAS O'BRIEN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PALOMAR MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000881695 STANDARD INDUSTRIAL CLASSIFICATION: PRINTED CIRCUIT BOARDS [3672] IRS NUMBER: 043128178 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-46869 FILM NUMBER: 99633033 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 7816767300 MAIL ADDRESS: STREET 1: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LOGG INVESTMENT RESEARCH INC CENTRAL INDEX KEY: 0001067408 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 880381219 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: PO BOX 4985 CITY: STATELINE STATE: NV ZIP: 89449 BUSINESS PHONE: 7025582192 MAIL ADDRESS: STREET 1: P O BOX 4985 CITY: STATELINE STATE: NV ZIP: 89449 SC 13D/A 1 AMENDMENT TO SCHEDULE 13D/A ------------------------------------------- OMB APPROVAL ------------------------------------------- OMB Number: Expires: Estimated average burden hours per form................... ------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* Palomar Medical Technologies, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 697529-10-5 - -------------------------------------------------------------------------------- (CUSIP Number) Adam D. Eilenberg Ehrenreich Eilenberg Krause & Zivian LLP 11 East 44th Street, 17th Floor New York, N.Y. 10017 (212) 986-9700 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 24, 1999 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement of Schedule 13G to report the acquisition which is the subject of the Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. *The remainder of this cover page shall be filed out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) CUSIP No. 697529-10-5 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Rockside Foundation - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER 772,658 (including 257,143 warrants SHARES exercisable at $21.00 per share (the "Warrants")) BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 1,737,382 (including 428,562 Warrants) REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 772,658 (including 257,143 Warrants) -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.18% (12.70% if not taking into account 428,562 Warrants) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 697529-10-5 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Mark T. Smith - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 530,451 (including 171,429 Warrants) BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 1,737,382 (including 428,562 Warrants) REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 530,451 (including 171,429 Warrants) -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.18% (12.70% if not taking into account 428,562 Warrants) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 697529-10-5 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Logg Investment Research, Inc. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 858 BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 1,737,382 (including 428,562 Warrants) REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 858 -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.18% (12.70% if not taking into account 428,562 Warrants) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 697529-10-5 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Thomas O'Brien - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 2,586 BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 1,737,382 (including 428,562 Warrants) REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 2,586 -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.18% (12.70% if not taking into account 428,562 Warrants) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 697529-10-5 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The R. Templeton Smith Foundation - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 430,829 BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 1,737,382 (including 428,562 Warrants) REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 430,829 -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,737,382 (including 428,562 Warrants) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.18% (12.70% if not taking into account 428,562 Warrants) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Schedule 13D Item 1. Security and Issuer This statement relates to the Common Stock, $.01 par value, of Palomar Medical Technologies, Inc. (the "Issuer"), which has its principal executive office at 45 Hartwell Avenue, Lexington, MA 02173. This statement is filed pursuant to Rule 13d-2(a) with respect to securities owned by the reporting persons specified herein as of May 24, 1999 and amends the Schedule 13 D filed on August 3, 1998, Amendment No. 1 filed on December 22, 1998, Amendment No. 2 filed on January 25, 1999, Amendment No. 3 filed on February 16, 1999 and Amendment No. 4 filed on April 15, 1999 ("Amendment No. 4"; collectively the "Schedule 13D"). Except as set forth herein, the Schedule 13D is hereby restated in its entirety. Item 4. Purpose of Transaction On May 24, 1999, The Monterey Stockholders Group LLC ("Monterey") issued a press release and filed soliciting material pursuant to Rule 14a-11(c) of the Securities Exchange Act of 1934, disclosing the intention of Monterey and the Reporting Persons to commence a solicitation of proxies to elect directors of the Issuer at the Issuer's upcoming annual meeting, in opposition to the directors nominated by the Issuer's current Board. The annual meeting is scheduled to be held on June 23, 1999. Monterey intends to file preliminary proxy materials pursuant to the Securities Exchange Act of 1934 as soon as practicable. The Reporting Persons are the sole members of Monterey, a Delaware limited liability company, and are utilizing Monterey for the purpose of commencing the proxy solicitation referred to above. A copy of Monterey's press release is filed as an exhibit to this Amendment No. 5 to the Schedule 13D. Although they have no current intention to do so, depending on market conditions and other factors, the Reporting Persons may acquire additional shares, or, subject to the provisions of Section 16 of the Exchange Act, sell all or a portion of their shares of Common Stock or Warrants. Except as described in the foregoing paragraph, the Reporting Persons have no plans or proposals which relate to or would result in any of the actions set forth in subparagraphs (a) through (j) of Item 4. Item 5. Interest in Securities of the Issuer See Items 7 through 13 of the Schedule 13D cover page. The stockholdings of the Reporting Persons have been adjusted from those reported in Amendment No. 4 to reflect a one for seven reverse share split (the "Reverse Split") recently effected by the Issuer, as reflected in its Report on Form 10-Q for the period ended March 31, 1999. The percentages of ownership of each Reporting Person, however, have not changed, and no securities of the Issuer have been acquired or disposed of by the Reporting Persons since the date of Amendment No. 4. Monterey does not own any securities of the Issuer. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer As previously reported in the Schedule 13D, two of the Reporting Persons, The Rockside Foundation ("Rockside") and Mark T. Smith ("Smith"), collectively acquired on July 24, 1998 from the Company, on a pre-Reverse Split basis, 3,000,000 shares of Common Stock of the Issuer and 3,000,000 Warrants (each a "Warrant" and collectively the "Warrants") to purchase an equivalent number of shares of Common Stock, for a price of $1.00 for each share of Common Stock and Warrant (an aggregate of $3,000,000). Rockside purchased 1,800,000 shares of Common Stock and Warrants and Smith purchased 1,200,000 shares of Common Stock and Warrants. The Stock Purchase Agreement with respect to such securities provided, among other things, that for so long as each purchaser continues to hold shares of Common Stock purchased thereunder, the Issuer would pay to such purchaser $0.0125 per share for the three month period ending November 30, 1998 and each three month period thereafter (an aggregate of $.05 per annum; equal to $.35 per annum after taking into account the Reverse Split). Item 7. Materials to be Filed as Exhibits Exhibit 99.1 Press Release dated May 24, 1999 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: May 24, 1999 THE ROCKSIDE FOUNDATION By: /s/ John B. Haley ---------------------------------- Name: John B. Haley Title: President /s/ Mark T. Smith ---------------------------------- Mark T. Smith LOGG INVESTMENT RESEARCH, INC. By: /s/ Thomas O'Brien ---------------------------------- Name: Thomas O'Brien Title: President /s/ Thomas O'Brien ---------------------------------- Thomas O'Brien THE R. TEMPLETON SMITH FOUNDATION By: /s/ Edward C. Smith ---------------------------------- Name: Edward C. Smith Title: Treasurer (120496DTI) Exhibit Index Exhibit Number Title Page - -------------- ----- ---- 99.1 Press Release dated May 24, 1999 EX-99.1 2 PRESS RELEASE FOR IMMEDIATE RELEASE CONTACT: Mark Harnett MacKenzie Partners (212) 929-5500 THE MONTEREY STOCKHOLDERS GROUP LLC TO COMMENCE PROXY SOLICITATION FOR DIRECTORS OF PALOMAR MEDICAL TECHNOLOGIES, INC. NEW YORK, NEW YORK, May 24, 1999 - The Monterey Stockholders Group LLC announced today that it intends to commence a solicitation of proxies to elect directors of Palomar Medical Technologies, Inc. (NASDAQ/SmallCap: PMTID) at the Company's upcoming annual meeting, in opposition to the directors nominated by the Company's current Board. The annual meeting is currently scheduled to be held on June 23, 1999. Monterey is owned by Mr. Mark Smith and other investors who control an aggregate of approximately 12.7%(excluding warrants) of the Company's outstanding Common Stock. Monterey is seeking to enhance stockholder value from current levels, which it believes are reflective of negative investor perceptions in the marketplace. In Monterey's view, the Board has not been sufficiently focused on stockholder interests. Monterey presently anticipates that if its nominees are elected, the new Board will retain existing management while conducting a thorough strategic review of the Company's operations and business opportunities, with a view towards more effectively using the Company's capital and other resources. Monterey believes that the individuals it intends to nominate as directors - Mark Smith, George Murphy, Jay Delahanty and Michael Marks -- have the experience necessary to plan and implement an effective business strategy for the Company and will enhance stockholder value. Monterey intends to file preliminary proxy materials pursuant to the Securities Exchange Act of 1934 as soon as practicable. CERTAIN INFORMATION CONCERNING PARTICIPANTS The following is a list of the names and stockholdings, if any, of persons who may be deemed to be "participants" in Monterey's solicitation with respect to the Company's annual meeting. These stockholdings reflect a one for seven reverse share split recently effected by the Company, as reflected in its Report on Form 10-Q for the period ended March 31, 1999: Mark Smith (359,022 shares of Common Stock and 171,429 warrants to purchase shares of Common Stock at an exercise price of $21 per share); The Rockside Foundation (515,515 shares of Common Stock and 257,143 warrants to purchase shares of Common Stock at an exercise price of $21 per share); The R. Templeton Smith Foundation (430,829 shares of Common Stock); Logg Investment Research, Inc. (858 shares of Common Stock); Thomas O' Brien (2,586 shares of Common Stock); and Messrs. Murphy, Delahanty and Marks, none of whom own any of the Company's securities. -----END PRIVACY-ENHANCED MESSAGE-----